Risk stratification for invasive aspergillosis in immunocompromised patients
- PMID: 23231711
- DOI: 10.1111/j.1749-6632.2012.06829.x
Risk stratification for invasive aspergillosis in immunocompromised patients
Abstract
Severe prolonged neutropenia, allogeneic hematopoietic stem cell or solid-organ transplantation, corticosteroids or other T cell suppressive agents, and other severe immunosuppressive factors have for many years been considered to predispose patients to invasive aspergillosis. Other conditions such as impaired innate immunity, diabetes, renal impairment, progression of the underlying malignancy, prior respiratory disease, and nosocomial or environmental exposure to fungal spores or climatic factors have recently been considered additional risk factors of invasive aspergillosis. The multiplicity of risk factors as well as the obvious synergy between them renders risk stratification difficult. An international, large-scale, multicenter, epidemiological study is necessary to develop a risk score.
© 2012 New York Academy of Sciences.
Similar articles
-
Invasive aspergillosis in 2002: an update.Eur J Clin Microbiol Infect Dis. 2002 Mar;21(3):161-72. doi: 10.1007/s10096-002-0699-z. Epub 2002 Mar 22. Eur J Clin Microbiol Infect Dis. 2002. PMID: 11957017 Review.
-
Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S119-23. doi: 10.1016/S0924-8579(08)70012-8. Int J Antimicrob Agents. 2008. PMID: 19013335 Review.
-
Aspergillus infections in the critically ill.Proc Am Thorac Soc. 2010 May;7(3):204-9. doi: 10.1513/pats.200906-050AL. Proc Am Thorac Soc. 2010. PMID: 20463249
-
Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.J Pediatr Hematol Oncol. 2009 Sep;31(9):642-6. doi: 10.1097/MPH.0b013e3181acd956. J Pediatr Hematol Oncol. 2009. PMID: 19684521
-
Clinical risk factors for invasive aspergillosis.Med Mycol. 2011 Apr;49 Suppl 1:S7-S12. doi: 10.3109/13693786.2010.505204. Epub 2010 Aug 18. Med Mycol. 2011. PMID: 20718606 Review.
Cited by
-
Performance, Correlation and Kinetic Profile of Circulating Serum Fungal Biomarkers of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies.J Fungi (Basel). 2021 Mar 13;7(3):211. doi: 10.3390/jof7030211. J Fungi (Basel). 2021. PMID: 33805751 Free PMC article.
-
Aspergillus fumigatus and Aspergillosis in 2019.Clin Microbiol Rev. 2019 Nov 13;33(1):e00140-18. doi: 10.1128/CMR.00140-18. Print 2019 Dec 18. Clin Microbiol Rev. 2019. PMID: 31722890 Free PMC article. Review.
-
Rate, Risk Factors, and Outcomes of Invasive Fungal Infections in Patients with Hematologic Malignancies.Int J Hematol Oncol Stem Cell Res. 2024 Jan 1;18(1):75-82. doi: 10.18502/ijhoscr.v18i1.14746. Int J Hematol Oncol Stem Cell Res. 2024. PMID: 38680718 Free PMC article.
-
Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?".Antimicrob Agents Chemother. 2014 Aug;58(8):4990-1. doi: 10.1128/AAC.03224-14. Antimicrob Agents Chemother. 2014. PMID: 25028731 Free PMC article. No abstract available.
-
Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study.Infect Dis Ther. 2020 Dec;9(4):807-821. doi: 10.1007/s40121-020-00331-4. Epub 2020 Aug 28. Infect Dis Ther. 2020. PMID: 32860206 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical